Business Wire

NEC Face Recognition Technology Ranks First in NIST Accuracy Testing

Share

NEC Corporation (NEC; TOKYO: 6701), a leader in the integration of IT and network technologies, today announced that its face recognition technology achieved the highest matching accuracy in the Face Recognition Vendor Test (FRVT) 2018 (*1) performed by the U.S. National Institute of Standards and Technology (NIST), with an error rate of 0.5% when registering 12 million people (*2).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191003005492/en/

Comparing Identification Accuracy and Search Speed in NIST FRVT2018 (Graphic: Business Wire)

Comparing Identification Accuracy and Search Speed in NIST FRVT2018 (Graphic: Business Wire)

NEC’s technology ranked No. 1 in NIST testing for the fifth time, following its top placement in the face recognition testing for video in 2017. The high performance of NEC’s technology is reflected in the test results which placed the company significantly ahead of the runner-up.

In recent years, the growing convenience of biometric authentication technology, improved security awareness, and the remarkable development of artificial intelligence (AI), have driven companies around the world to begin adopting biometric authentication technology. Specifically, the use of face recognition technology is rapidly expanding across a wide range of fields throughout the world. Face recognition technologies are now being used in areas that require high reliability, convenience and long-term use, such as identity verification and national infrastructure, transaction settlements, bank account establishment, and passport verification.

49 organizations, including companies from the United States, China, Russia, Europe, and Japan, participated in the NIST’s FRVT 2018, where the evaluation of face recognition accuracy was performed. These tests are the most rigorous and fair benchmarks implemented by the NIST as each organization is required to submit and be evaluated on programs that were developed during the same period. By performing multi-stage matching, an impressive search speed of 230 million matchings per second was achieved. Furthermore, leveraging NEC's deep learning methods to significantly reduce the identification error rate, NEC accurately matched images of a subject taken over a 10 year interval with an error rate that was 4 times lower than the runner-up.

Going forward, NEC aims to further expand the scope of this technology’s application to include store transaction settlements, services in public facilities, such as buses, railways, airports, city offices, and hospitals; and helping to protect and care for children and the elderly. Based on the NEC Group AI and Human Rights Principles established in April of this year (*3), NEC gives top priority to the consideration of privacy and respect for human rights when using AI and biometric data. NEC also aims to contribute to further improvements in the usability of biometric identification and video analytics technology, including face recognition.

“NEC’s portfolio of biometric identification solutions, ‘Bio-IDiom’ (*4), which includes face recognition technology, is critical to the ways that NEC is helping to build safer and more productive societies as part of the ‘NEC Value Chain Innovation’,” said Hitoshi Imaoka, NEC Fellow at NEC Corporation. “These technologies create new value by sharing information on the status of communities, things, and processes across the entire value chain, and are a meaningful source of growth in our Mid-term Management Plan 2020 and ‘NEC Safer Cities’ (*5), which support the realization of safe, secure, efficient, and equal cities.”

Notes:

(*1)

The Face Recognition Vendor Test 2018 (FRVT 2018), sponsored by the US Department of Homeland Security and others, assessed the accuracy and speed of authentication for tens of millions of people using face recognition technologies from top vendors from throughout the world.

https://www.nist.gov/programs-projects/frvt-1n-identification

 

(*2)

Patrick Grother, Mei Ngan, Kayee Hanaoka, Face Recognition Vendor Test (FRVT), NIST Interagency Report 8271(2019/09/11)

https://www.nist.gov/sites/default/files/documents/2019/09/11/nistir_8271_20190911.pdf

 

(*3)

NEC Unveils "NEC Group AI and Human Rights Principles"

https://www.nec.com/en/press/201904/global_20190402_01.html

 

(*4)

Bio-IDiom

https://www.nec.com/en/global/solutions/biometrics/index.html

 

(*5)

NEC Safer Cities

https://www.nec.com/en/global/solutions/safercities/index.html

About NEC Corporation
For more information, visit NEC at http://www.nec.com.

Contact information

NEC Corporation
Joseph Jasper
Corporate Communications Division
j-jasper(at)ax.jp.nec.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

 Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI® (lumacaftor/ivacaftor) in Children Ages 2 to 5, With Certain CFTR Mutations in Australia19.10.2019 23:29:00 CESTPress release

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the F508del mutation and another responsive residual function (RF) mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. People with CF who have one copy of the F508del mutation and another responsive RF mutation in the CFTR gene will have access to a medicine for the cause of their CF for the first time. In addition, ORKAMBI® (lumacaftor/ivacaftor) is now also reimbursed for the treatment of children with CF ages 2 to 5 who have two copies of the F508del mutation in the CFTR gene. Patients over the age of 6 have already been able to access ORKAMBI® in Australia since October 2018. Following previously received positive recommendations from the Pharmaceutical Benefits Advisory Committee (PB

A&D Resources utvider i Norden19.10.2019 12:57:00 CESTPress release

A&D Resources, den autoriserte distributøren for Hogan Assessments i Danmark og Benelux-landene, utvider forretningsdriften til Finland, Norge og Sverige, noe som gjøre det til den fremste Hogan-distributøren i regionen. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20191019005034/no/ A&D spesialiserer seg i evaluering og utvikling av enkeltpersoner, grupper og organisasjoner, og er ansett som den fremste evalueringsvirksomheten i Danmark. Denne utvidelsen i Norden kan i stor grad tilskrives organisasjonens suksesshistorie i den omliggende regionen og også på grunn av dens arbeid globalt. «Vi er heldige som har et sterkt omdømme innenfor vår bransje, enten det er i Danmark, Benelux eller utover, og det er fordi vi leverer», sier Hans Ove Dahl, administrerende direktør i A&D. «Vi mener at hvis du bygger opp et talentfullt team ved å bruke Hogans evalueringer, som er allment betraktet som de mest prediktive evalueringene

EURid Launches New Eligibility Criteria19.10.2019 04:30:00 CESTPress release

The top-level internet domain .eu is the eighth largest country code extension on the internet and, as of October 2019, we have more than 3.6 million registrations spread out across Europe. Since its launch in 2006, only companies and individuals residing within the EU and EEA member states have been eligible to register the .eu domain name. However, striving to meet the needs of an ever-changing digital environment, the eligibility criteria for the registration of .eu domain name has now been extended to all EU citizens living around the world. With millions of Europeans living around the world – our hope is to provide these individuals, living far from their native lands, with a personal online platform through which they can share their stories with families and friends back home. “We are excited to be able to extend the registration criteria to EU citizens around the world. The .eu domain is now closer to your ambitions, achievements and dreams. It is the bridge connecting you to y

ams to Launch New Takeover Offer for OSRAM at EUR 41.00 Per Share With Minimum Acceptance Threshold of 55%18.10.2019 17:16:00 CESTPress release

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces that it intends to launch a new all-cash takeover offer for OSRAM Licht AG ("OSRAM") for 100% of the share capital of OSRAM at a price of EUR 41.00 per share ("Offer"). The Offer which represents a premium of 42% to the undisturbed OSRAM share price of EUR 28.92 as of 2 July 2019 will be launched by ams Offer GmbH, a newly incorporated, wholly owned subsidiary of ams. ams is the largest shareholder in OSRAM with a direct shareholding of 19.99% which ams will not exceed outside of the Offer. As a result of ams' shareholder position, ams has lowered the minimum acceptance threshold to 55%. Winning way forward for ams and OSRAM The combination of ams and OSRAM allows ams to create a global leader in sensor solutio

Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe18.10.2019 15:38:00 CESTPress release

Resecurity, a cybersecurity company that delivers in-depth analysis layered on top of the most comprehensive, exclusive sets of data from the Deep and Dark Web, announces that Selene Giupponi has joined as Managing Director and will be based in Italy. A digital forensics expert, Selene adds significant value to Resecurity’s operations in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191018005415/en/ Resecurity Appoints Selene Giupponi Managing Director of Resecurity Europe (Photo: Business Wire) Selene has extensive expertise in digital forensics and is often called as an expert witness regarding digital and mobile forensics on domestic and international cases, investigations and court trials. She is a specialized IT trainer in Italy and teaches digital, mobile, cloud and mainframe forensics, cybercrime and information security at various Italian universities. “Selene brings a depth of experience to our team and we

Secure-24 Completes Acquisition of Symmetry Corporation18.10.2019 14:20:00 CESTPress release

NTT Ltd., the newly formed, world-leading global technology services provider, and Symmetry Holding Inc. (Symmetry), a U.S.-based leading provider of SAP managed services, today announced that Secure-24 Intermediate Holdings, Inc. (Secure-24), part of the Managed Services division of NTT Ltd., has completed the acquisition of Symmetry Corporation effective October 17, 2019. “The powerful business combination of Secure-24 and Symmetry leverages the strengths of both companies around Secure-24’s foundation of delivering managed IT operations, application hosting and cloud services to enterprises worldwide,” said Mike BeDell, Chief Executive Officer, Secure-24. “As we begin to integrate Symmetry’s portfolio into Secure-24’s portfolio, through a shared vision, we look forward to providing even greater value that accelerates our clients’ business success.” Symmetry, headquartered in Brookfield, Wisconsin, will expand the scale of SAP managed services capabilities of Secure-24 and bring new